The study population consisted of 492 patients undergoing PNA of the lung for benign or malignant lesions at the Medical University of South Carolina Hospital between 1980 and 1985. Patient names were cross-referenced in our pulmonary function laboratory; and 192 were identified to have had pulmonary function testing. Patients were included for analysis if their pulmonary function tests met one of the following criteria: (1) PFT within 12 months of the procedure; (2) severe obstruction or restriction by PFT prior to the procedure, without subsequent evidence of clinical improvement; or (3) normal PFT after the procedure. One hundred fifty-nine patients met these inclusion criteria and formed the patient population. Pulmonary function including simple spirometry was tested with the DS Plus System (Warren E. Collins). The best of at least three efforts was selected for study purposes. Patients were classified according to the following pulmonary function criteria: obstructive: FEVi or FVC <70 percent, with FEV/FVC ratio <70 percent; restrictive: FVC <70 percent, with FEV/FVC ratio >70 percent; and normal: FEVi, FVC, and FEVVFVC ratio >70 percent.
MATERIAL AND METHODS
The study population consisted of 492 patients undergoing PNA of the lung for benign or malignant lesions at the Medical University of South Carolina Hospital between 1980 and 1985. Patient names were cross-referenced in our pulmonary function laboratory; and 192 were identified to have had pulmonary function testing. Patients were included for analysis if their pulmonary function tests met one of the following criteria: (1) PFT within 12 months of the procedure; (2) severe obstruction or restriction by PFT prior to the procedure, without subsequent evidence of clinical improvement; or (3) normal PFT after the procedure. One hundred fifty-nine patients met these inclusion criteria and formed the patient population. Pulmonary function including simple spirometry was tested with the DS Plus System (Warren E. Collins). The best of at least three efforts was selected for study purposes. Patients were classified according to the following pulmonary function criteria: obstructive: FEVi or FVC <70 percent, with FEV/FVC ratio <70 percent; restrictive: FVC <70 percent, with FEV/FVC ratio >70 percent; and normal: FEVi, FVC, and FEVVFVC ratio >70 percent.
Preprocedure standard 6-foot posterior-anterior (PA) and lateral chest roentgenograms were interpreted by three unbiased radiologists utilizing the following criteria: (1) obstructive disease, if three of the following four criteria were met: hyperinflation, paucity of vascular markings, flattening of hemidiaphragms, or bullous lesions; (2) restrictive disease, if two of the following three criteria were met: small lung volumes, increased interstitial markings, or diffuse interstitial markings; and (3) normal, those who failed to meet the above criteria of obstruction or restriction. If there was disagreement among the three radiologists, the x-ray film was characterized by majority vote. Other variables recorded for analysis included lesion size measured as the greatest diameter of the lesion on PA or lateral roentgenogram, lesion depth as measured from the pleural surface to the edge of the lesion on PA or lateral roentgenogram (whichever was less), number of needle passes, age, sex, FEVb and FVC.
The procedure was performed by radiology residents under the direct supervision of a certified radiologist utilizing biplaner fluoroscopy or CT guidance. No patient had supplemental oxygen administered during the procedure in an effort to decrease the incidence of pneumothorax or to alter its clinical importance. A 22-gauge Chiba needle was used in all cases (as previously described), and the approach was planned to traverse a minimal number of pleural planes. 9 Material aspirated was sent for rapid cytologic analysis, and, if inadequate or nondiagnostic, the procedure repeated immediately Intraprocedure development of PTX precluded additional attempts. Postprocedure expiratory roentgenograms were obtained to search for the presence of PTX. Outpatients had followup films immediately and six hours after the procedure. If negative, they were discharged with instructions to obtain a chest roentgenogram locally if sudden shortness of breath developed. No such delayed pneumothorax developed. Immediate and six-hour postprocedure, as well as routinely ordered, films of in-patients were examined for a 48-hour period to look for PTX. None developed after the first six hours. The PTX was treated based on current clinical guidelines. 14 The significance of PFT and CXR interpretation in predicting the PTX rate were analyzed by x 2 testing. Individual variables were analyzed by Student's t test or weighted x 2 -Linear regression analysis was utilized to provide a pneumothorax prediction equation.
RESULTS
Of the group of 159 patients investigated, 128 were men and 31 women. Comparison of variables in relation to development of PTX are shown in Table 1 . In addition, we analyzed the next 88 patients undergoing the procedure over the following 18 months to determine if the above formula was accurate when applied to patients. As seen in Table 3 that could be predicted by a simple formula. The smaller the lesion, and the greater the depth of needle penetration, the more likely was the association of PTX. Although the importance of age, sex, and number of needle passes has been previously emphasized, 5 -6 s 1013 these were not found to be predictors.
That PFT interpretation enhances the PTX prediction rate is not surprising. Poe et al 13 and Sinner 8 suggested that obstructive lung disease by radiographic criteria increased the risk of PTX in patients undergoing PNA. Although the PFT criteria utilized here measure large airway flows, they imply certain information about the underlying lung parenchyma. Obstruction by PFT criteria is most commonly seen in emphysema and chronic bronchitis, conditions that are associated with an independent risk of PTX even in the absence of manipulation. 15 Restriction by PFT criteria imply stiff, fibrotic lungs, unable to seal quickly after an invasive needle aspiration. In both cases, abnormal PFT were associated with an increased PTX rate when compared with patients with normal PFT.
In conjunction with this, FEV,, an important PFT parameter in both restrictive and obstructive lung disease, correlated significantly with the development of PTX, to the point that linear regression analysis allowed significant formula quantification of this risk. lesions was the significant factor in PTX development, not simply the number of passes. The longer the needle remains in the chest, the greater the chance of tearing the pleura as the patient breathes or coughs.
If one were to measure dwell time of the needle in the chest, an increasing PTX rate proportional with dwell time might be noted.
The spirometric measurements recommended here to assess the risk of PTX are simple to perform, easy to interpret, reproducible, and not expensive. They can be measured just prior to the procedure to quickly predict the PTX risk. With simple equipment, the cost of spirometry should be well under $50. Although not absolutely necessary to perform in all patients prior to biopsy, spirometric testing is benign, and since many aspirated lesions are neoplastic, the spirometric evaluation would eventually be routine, making the majority of such tests ultimately appropriate.
In conclusion, our study has shown that PFT and CXR analysis should be helpful in predicting the PTX 
